| Product Code: ETC8833902 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The adult vaccine market in the Philippines is evolving, driven by increasing awareness of preventable diseases like influenza, hepatitis, shingles, and COVID-19. Government-led immunization programs and private healthcare initiatives are pushing adult vaccination coverage. While public uptake is rising, misinformation and cost barriers still exist. Future growth is expected through workplace wellness programs, travel-related vaccinations, and expanded access via community clinics.
The adult vaccine market is witnessing robust growth as public health initiatives emphasize immunization beyond childhood, targeting diseases like influenza, pneumococcal infections, and hepatitis. Rising awareness of vaccine-preventable diseases, expanding healthcare infrastructure, and government vaccination campaigns drive market expansion. Increasing private sector involvement and vaccine availability enhance coverage.
Vaccine hesitancy, partly due to past controversies, affects the adult vaccine market in the Philippines. Limited public awareness campaigns and insufficient government funding for adult immunization programs contribute to low vaccination rates. Additionally, logistical challenges in vaccine distribution hinder accessibility in remote areas.
The adult vaccine market in the Philippines is growing due to increased awareness of preventable diseases and employer-driven vaccination programs. Opportunities exist in expanding access to influenza, pneumococcal, HPV, and hepatitis vaccines. Companies can invest in mobile immunization clinics, cold chain logistics, and education initiatives aimed at adults, especially in urban workplaces and community health programs.
Vaccination policies in the Philippines increasingly target adults for diseases such as influenza, pneumococcal infections, and COVID-19. The DOH implements adult immunization programs through public health campaigns and subsidized vaccine distribution, supported by regulatory frameworks that ensure vaccine safety and efficacy. Policies also promote private sector participation to expand vaccine coverage.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Adult Vaccine Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Adult Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Adult Vaccine Market - Industry Life Cycle |
3.4 Philippines Adult Vaccine Market - Porter's Five Forces |
3.5 Philippines Adult Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Adult Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Philippines Adult Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Philippines Adult Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
4 Philippines Adult Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of adult vaccinations in preventing diseases |
4.2.2 Government initiatives and programs promoting adult vaccination |
4.2.3 Growing healthcare infrastructure and facilities in the Philippines |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas |
4.3.2 Lack of awareness about specific adult vaccines and their benefits |
4.3.3 Affordability and cost of vaccines for adults in the Philippines |
5 Philippines Adult Vaccine Market Trends |
6 Philippines Adult Vaccine Market, By Types |
6.1 Philippines Adult Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Adult Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Adult Vaccine Market Revenues & Volume, By Subunit, 2021- 2031F |
6.1.4 Philippines Adult Vaccine Market Revenues & Volume, By mRNA, 2021- 2031F |
6.1.5 Philippines Adult Vaccine Market Revenues & Volume, By Inactivated, 2021- 2031F |
6.1.6 Philippines Adult Vaccine Market Revenues & Volume, By Live attenuated, 2021- 2031F |
6.1.7 Philippines Adult Vaccine Market Revenues & Volume, By Viral Vector, 2021- 2031F |
6.2 Philippines Adult Vaccine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Philippines Adult Vaccine Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Philippines Adult Vaccine Market Revenues & Volume, By Nasal, 2021- 2031F |
6.2.4 Philippines Adult Vaccine Market Revenues & Volume, By Prenteral, 2021- 2031F |
6.3 Philippines Adult Vaccine Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Philippines Adult Vaccine Market Revenues & Volume, By Viral Diseases, 2021- 2031F |
6.3.3 Philippines Adult Vaccine Market Revenues & Volume, By Bacterial Vaccines, 2021- 2031F |
6.3.4 Philippines Adult Vaccine Market Revenues & Volume, By Cancer Vaccines, 2021- 2031F |
6.3.5 Philippines Adult Vaccine Market Revenues & Volume, By Allergy Vaccines, 2021- 2031F |
6.4 Philippines Adult Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Philippines Adult Vaccine Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.3 Philippines Adult Vaccine Market Revenues & Volume, By Pediatric, 2021- 2031F |
7 Philippines Adult Vaccine Market Import-Export Trade Statistics |
7.1 Philippines Adult Vaccine Market Export to Major Countries |
7.2 Philippines Adult Vaccine Market Imports from Major Countries |
8 Philippines Adult Vaccine Market Key Performance Indicators |
8.1 Percentage increase in adult vaccination coverage rates |
8.2 Number of adults receiving recommended vaccines |
8.3 Rate of adherence to adult vaccination schedules |
9 Philippines Adult Vaccine Market - Opportunity Assessment |
9.1 Philippines Adult Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Adult Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Philippines Adult Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Philippines Adult Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
10 Philippines Adult Vaccine Market - Competitive Landscape |
10.1 Philippines Adult Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Philippines Adult Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |